Lanean...
Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
Anti-programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) antibodies are currently used in the clinic to interupt the PD-1/PD-L1 immune checkpoint, which reverses T cell dysfunction/exhaustion and shows success in treating cancer. Here, we report a histone demethylase inhibitor, 5-c...
Gorde:
| Argitaratua izan da: | Nat Commun |
|---|---|
| Egile Nagusiak: | , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group UK
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8065121/ https://ncbi.nlm.nih.gov/pubmed/33893275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-021-22407-6 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|